文献速递外周动脉疾病

长段股浅动脉闭塞性疾病覆膜支架置入术后边缘狭窄:危险因素分析与药物涂层球囊血管成形术的预防作用

Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty.
PubMed 文献 · J Endovasc Ther · 2018-04-20

该回顾性分析纳入2011年10月至2016年7月110例因长段股浅动脉闭塞接受Viabahn覆膜支架治疗的患者,其中38例(34.5%)在支架远端边缘行药物涂层球囊(DCB)强化。DCB强化降低了边缘狭窄(p=0.021)和靶病变血运重建(TLR;p=0.010)的发生率,并显著提高1年一期通畅率(92.1% vs 76.4%,p=0.042)。多因素分析显示仅远端流出道不良(OR 0.31,95%CI 0.11至0.83,p=0.020)是边缘狭窄的预测因素。

要点

  • DCB强化使1年一期通畅率从76.4%提高至92.1%(p=0.042)。
  • DCB强化降低边缘狭窄(p=0.021)和1年TLR(p=0.010)发生率。
  • 远端流出道不良是边缘狭窄的唯一独立预测因素(OR 0.31,95%CI 0.11至0.83,p=0.020)。

核心结论

  • Viabahn覆膜支架置入术后边缘狭窄风险在远端流出道不良患者中更高。
  • 支架远端边缘DCB强化可减少边缘狭窄、降低1年TLR并改善1年一期通畅率。

研究设计与样本

  • 回顾性分析,2011年10月至2016年7月纳入110例(平均年龄73.3±7.6岁;78例男性)因长段股浅动脉闭塞接受Viabahn覆膜支架治疗的患者。
  • 38例(34.5%)患者在支架远端边缘行DCB强化。
  • 分析时分为无边缘狭窄组(n=88;平均病变长度22.4±4.2 cm)和边缘狭窄组(n=22;平均病变长度23.5±5.7 cm),至少随访12个月比较临床结局、踝肱指数、CT血管造影表现和通畅率。
  • 采用逻辑回归分析确定边缘狭窄的危险因素,结果以比值比(OR)和95%置信区间表示。

主要发现

  • 除边缘狭窄组糖尿病发生率更高(p=0.008)和逆行入路需求更大(p=0.033)外,两组临床或手术特征无差异。
  • DCB强化降低边缘狭窄发生率(p=0.021)和靶病变血运重建(TLR;p=0.010),并使1年一期通畅率显著更高(92.1% vs 76.4%,p=0.042)。
  • 多因素分析显示仅远端流出道不良(OR 0.31,95%CI 0.11至0.83,p=0.020)是边缘狭窄的预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report a retrospective analysis of risk factors for edge restenosis after Viabahn stent-graft treatment of superficial femoral artery (SFA) occlusive disease and determine any protective effect of drug-coated balloons (DCBs) used at the time of stent-graft implantation. METHODS: Between October 2011 and July 2016, 110 patients (mean age 73.3±7.6 years; 78 men) were treated with the Viabahn stent-graft for long SFA occlusions. Thirty-eight (34.5%) patients had DCB reinforcement at the distal edge of the stent-graft. For analysis, the population was divided into groups of no edge stenosis patients (n=88; mean lesion length 22.4±4.2 cm) and edge stenosis patients (n=22; mean lesion length 23.5±5.7 cm). The clinical outcomes, ankle-brachial indices, computed tomography angiography findings, and patency were compared at a minimum of 12 months. Logistic regression analysis was employed to determine risk factors for edge stenosis; the results are presented as the odds ratio (OR) and 95% confidence interval. RESULTS: No differences in clinical or procedural characteristics were identified except the higher incidence of diabetes (p=0.008) and greater need for retrograde access (p=0.033) in the edge stenosis group. DCB reinforcement reduced the incidence of edge stenosis (p=0.021) and target lesion revascularization (TLR; p=0.010) and resulted in a significantly higher 1-year primary patency rate (92.1% vs 76.4%, p=0.042). However, multivariate analysis revealed only poor distal runoff (OR 0.31, 95% CI 0.11 to 0.83, p=0.020) as a predictor of edge stenosis. CONCLUSION: The risk of edge stenosis after Viabahn implantation was higher in patients with poor distal runoff. DCB reinforcement over the distal edge reduced edge stenosis, decreased 1-year TLR, and improved 1-year primary patency.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Lin TC, Huang CY, Chen PL, et al. Edge Stenosis After Covered Stenting for Long Superficial Femoral Artery Occlusive Disease: Risk Factor Analysis and Prevention With Drug-Coated Balloon Angioplasty. J Endovasc Ther. 2018. PMID: 29673299. doi:10.1177/1526602818771345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。